Folger Nolan Fleming Douglas Capital Management Inc. Decreases Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Folger Nolan Fleming Douglas Capital Management Inc. lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 3.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 65,386 shares of the financial services provider’s stock after selling 2,444 shares during the quarter. iShares Biotechnology ETF comprises about 1.0% of Folger Nolan Fleming Douglas Capital Management Inc.’s holdings, making the stock its 26th largest holding. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in iShares Biotechnology ETF were worth $8,883,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. International Assets Investment Management LLC purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $76,425,000. Itau Unibanco Holding S.A. acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at approximately $48,242,000. Tower Research Capital LLC TRC raised its position in shares of iShares Biotechnology ETF by 28,138.4% during the 3rd quarter. Tower Research Capital LLC TRC now owns 98,552 shares of the financial services provider’s stock valued at $12,052,000 after acquiring an additional 98,203 shares in the last quarter. Calamos Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $7,648,000. Finally, Cumberland Advisors Inc. acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at approximately $6,297,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock traded up $0.82 on Friday, hitting $126.49. 833,050 shares of the stock traded hands, compared to its average volume of 1,534,186. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16. The company’s fifty day moving average is $134.45 and its 200 day moving average is $129.71.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.40%. The ex-dividend date was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.